MD Gerhard-Herman, HL Gornik, C Barrett… - Journal of the American …, 2017 - jacc.org
The recommendations listed in this guideline are, whenever possible, evidence based. An initial extensive evidence review, which included literature derived from research involving …
J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024 - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …
MD Gerhard-Herman, HL Gornik, C Barrett… - Circulation, 2017 - Am Heart Assoc
The recommendations listed in this guideline are, whenever possible, evidence based An initial extensive evidence review, which included literature derived from research involving …
JE Roeters van Lennep, LS Tokgözoğlu… - European heart …, 2023 - academic.oup.com
Cardiovascular disease is the leading cause of death in women and men globally, with most due to atherosclerotic cardiovascular disease (ASCVD). Despite progress during the last 30 …
Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an increasing amount of resources in the United States health care system. Overall rates of …
C Diehm, A Schuster, JR Allenberg, H Darius, R Haberl… - Atherosclerosis, 2004 - Elsevier
We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of …
ContextPersons with lower-extremity peripheral arterial disease (PAD) are often asymptomatic or have leg symptoms other than intermittent claudication (IC). ObjectiveTo …
MMG McDermott - Circulation research, 2015 - Am Heart Assoc
Lower extremity peripheral artery disease (PAD) is frequently underdiagnosed, in part because of the wide variety of leg symptoms manifested by patients with PAD and in part …